Indo Borax reported a 22.9% rise in revenue to ₹215.45 crore for FY26. The company recommended a record ₹40 per share dividend and plans a ₹20 crore Boron Oxide facility. A new promoter, Zenrock Chemicals, has taken control.
Indo Borax Delivers Strong FY26 Growth Amidst Ownership Change
Indo Borax & Chemicals Ltd reported a significant 22.9% increase in revenue from operations, reaching ₹215.45 crore for the fiscal year 2025-26. The company's standalone net profit also saw a healthy 18.8% jump to ₹49.74 crore.
Reader Takeaway: Record dividend and capacity expansion plans signal positive outlook; litigation risk remains a watch point.
What just happened
Indo Borax & Chemicals Ltd announced its financial results for FY 2025-26, showcasing robust revenue growth and a substantial increase in net profit. The company's Board has recommended a total dividend of ₹40 per share, the highest in its history, with a record date set for July 21, 2026. Additionally, the company plans to invest ₹20 crore in a new 4,000 MTPA Boron Oxide facility in Pithampur, aiming to tap into higher-margin markets. This period also marked a change in control, with Zenrock Chemicals Private Limited acquiring a majority stake, leading to the exit of the former promoter group.
Why this matters
The strong financial performance, coupled with a record dividend payout, indicates healthy operational efficiency and a robust cash position for Indo Borax. The strategic investment in a Boron Oxide facility signals a move up the value chain. The change in promoters suggests a potential strategic shift and renewed focus on growth initiatives under the new management.
The backstory
Indo Borax has historically been involved in the manufacturing of borax and boric acid. The recent acquisition by Zenrock Chemicals Private Limited marks a significant transition, bringing in new ownership and potentially a new strategic direction. The company's operations are sensitive to the costs of imported boron ores and global commodity prices.
What changes now
With Zenrock Chemicals at the helm, Indo Borax is poised for a phase of capacity expansion and market development. The immediate focus will be on establishing the new Boron Oxide facility and expanding its international presence. Investors can expect a greater emphasis on specialized boron-based products and R&D.
Risks to watch
The company faces litigation risk due to an Inter-Corporate Deposit (ICD) of ₹5.09 crore with Radius Estate Projects Private Limited, which is currently undergoing insolvency proceedings. Uncertainty surrounds the recovery of this amount. Furthermore, Indo Borax remains reliant on imported boron ores, exposing it to currency fluctuations and price volatility.
Peer comparison
While specific peer performance data for FY26 is not provided in the filing, Indo Borax's growth in revenue and profit is notable. The company's strategy to invest in value-added products like Boron Oxide could differentiate it from peers focused solely on basic boron chemicals.
Context metrics (time-bound)
- Operating Revenue: ₹215.45 Crore (FY 2025-26) vs ₹175.26 Crore (FY 2024-25) - a 22.9% increase.
- Consolidated Net Profit: ₹50.27 Crore (FY 2025-26, implied from filing snapshot) vs not specified for prior year.
- Standalone Profit for the Year: ₹49.74 Crore (FY 2025-26) vs ₹41.88 Crore (FY 2024-25) - an 18.8% increase.
- Total Dividend: ₹40 per share recommended for FY 2025-26.
- Capital Expenditure: ₹20 Crore planned for a new Boron Oxide facility.
What to track next
Investors should closely monitor the progress of the new Boron Oxide facility's construction and commissioning. Updates on the recovery status of the ICD with Radius Estate Projects will also be crucial. Further communication from the new management regarding strategic initiatives and R&D advancements will be important.